Scientists are to run a trial to see whether cannabis-based medicines can reduce disability in patients with multiple sclerosis. The three-year study, awarded £2 million by the Medical Research Council, will begin this year and will be led by John Zajicek of the Peninsula Medical School and Derriford Hospital, in collaboration with Professor Alan Thompson at the National Hospital for Neurology and Neurosurgery, part of University College London Hospitals NHS Foundation Trust.
Please
or to read this article.Register to continue
Get a month's unlimited access to THE content online. Just register and complete your career summary.
Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:
- Sign up for the editor's highlights
- Receive World University Rankings news first
- Get job alerts, shortlist jobs and save job searches
- Participate in reader discussions and post comments
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Subscribe
Already registered or a current subscriber?
